Publications by authors named "K Blot"

Purpose: The aim of this study was to assess whether there is a discrepancy between clinical and autopsy-based diagnoses in adult intensive care unit (ICU) patients.

Methods: We conducted a systematic review of cohort studies reporting on conventional autopsy-confirmed missed diagnoses. The discrepancy rate was per study calculated by dividing the number of patients with a missed diagnosis by the number of autopsies.

View Article and Find Full Text PDF

Objective: To describe the practice of ventilator-associated pneumonia (VAP) prevention and control through the incremental introduction of prevention strategies and assess the effect on VAP incidence.

Design: Historical observational surveillance study conducted over 13 years.

Setting: A 12-bed adult intensive care unit (ICU) in a general hospital in Belgium.

View Article and Find Full Text PDF
Article Synopsis
  • The classification system for intra-abdominal infections categorizes patients based on infection onset, peritonitis type, and disease severity, and has shown effective risk stratification in ICU settings.
  • A study focusing on 165 ICU patients with pancreatic infections found a mortality rate of 35.2%, with older age, localized peritonitis, and persistent inflammation as key risk factors.
  • Ultimately, the research indicates that ongoing inflammation and complications in managing pancreatic infections are critical for predicting short-term patient outcomes.
View Article and Find Full Text PDF

Background: Recent studies have identified important social inequalities in SARS-CoV-2 infections and related COVID-19 outcomes in the Belgian population. The aim of our study was to investigate the sociodemographic and socioeconomic characteristics associated with the uptake of COVID-19 vaccine in Belgium.

Methods: We conducted a cross-sectional analysis of the uptake of a first COVID-19 vaccine dose among 5 342 110 adults (≥18 years) in Belgium on 31 August 2021.

View Article and Find Full Text PDF

BackgroundThe Belgian COVID-19 vaccination campaign aimed to reduce disease spread and severity.AimWe estimated SARS-CoV-2 variant-specific vaccine effectiveness against symptomatic infection (VEi) and hospitalisation (VEh), given time since vaccination and prior infection.MethodsNationwide healthcare records from July 2021 to May 2022 on testing and vaccination were combined with a clinical hospital survey.

View Article and Find Full Text PDF